Health-care companies rose as traders bet the sector would benefit from the U.S. regulatory environment as legal challenges subside.
Moderna is adding two new production lines at the former Polaroid plant in Massachusetts where it manufactures its Covid-19 vaccine, part of a push to prepare for making booster shots.
Tarsus Pharmaceuticals said an experimental eye-disease drug showed promise in a mid-stage trial.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
06-21-21 1725ET
